CME (CME) stock
Last close $306.31 on 2026-11-19 (-1.27%) · Sector: Financial Services
CME Group runs one of the world's largest marketplaces for derivatives, which are contracts whose value is tied to things like interest rates, stock indexes, currencies, and commodities such as oil and metals. Businesses and traders use these markets to manage risk, and CME earns most of its money from fees on the trades and clearing services that flow through its exchanges.
CME's business has been strong, with operating margin (the share of revenue left after core running costs) around 66% over the latest quarters and revenue growth of 9.1%. Over the past year the stock returned 11.3% versus 9.7% for the S&P 500, so it has beaten the broader market. The shares trade about 6.9% below their 52-week high and sit above both their 50-day and 200-day averages. Insiders have been selling heavily, with 11 sales worth $18.3 million in the last 90 days, including $8.4 million from the chairman and CEO in November. After its last four earnings releases, the stock rose the next day each time, though some moves were small.
Key numbers
- Market cap: $109.9B
- Revenue (last 12 months): $6.98B
- Revenue growth: +9.1%
- Operating margin: 65.6%
- P/E: 25.1
- P/S: 15.7
- Debt to equity: 0.00
- Current ratio: 1.02
Quality score
Overall 59/100 · growth 37 · profitability 99 · financial health 68 · value 32
Performance and risk
1-year return +11.3% vs S&P 500 +9.7% · volatility 25.1% (S&P 500 13.8%) · largest drop -33.0% · beta -0.26
Stock move the day after earnings
- 2026-02-04: +0.5%
- 2026-04-22: +0.5%
- 2026-07-22: +5.0%
- 2026-10-21: +0.2%
Insider trades (12 months)
Bought $0.7M · sold $43.8M
CME stock research · CME options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.